Inspire Medical Systems, Inc. 8-K

What Happened

• On January 12, 2026, Inspire Medical Systems (INSP) issued a press release reporting preliminary, unaudited results for the quarter and full year ended December 31, 2025; these results are estimates and subject to change pending close and review procedures and completion of internal control processes.
• The board approved the appointment of Matthew J. Osberg as Chief Financial Officer effective the day after the company files its 2025 Form 10‑K. Richard J. Buchholz was named interim CFO and interim principal financial/accounting officer through filing of the 2025 10‑K.
• The company also disclosed that it will be using an investor presentation in January 2026 meetings; the press release and presentation are furnished as Exhibits 99.1 and 99.2 to the 8‑K.

Key Details

• Press release date: January 12, 2026; reporting period: quarter and year ended December 31, 2025 (preliminary, unaudited).
• New CFO Matthew J. Osberg: age 50; prior roles include CFO at Apogee Enterprises (2023–Jan 2026) and Helen of Troy (2021–2023); CPA (inactive); bachelor’s in accounting from Augsburg University.
• Osberg employment terms: $650,000 annual base salary; annual cash bonus target = 70% of base; eligible for long‑term incentive awards.
• Sign‑on and equity awards: $600,000 cash sign‑on (paid half at start, half after six months, clawback if he resigns without Good Reason or is terminated for Cause); eligible for PSUs valued at $1,500,000 (performance‑based vesting through 12/31/2028) and RSUs valued at $1,500,000 (vest in three equal annual installments).
• Severance on termination without Cause: 12 months of base salary plus target annual bonus paid over 12 months, plus 12 months subsidized COBRA; certain equity acceleration on a Change of Control subject to award terms.
• Interim CFO: Richard J. Buchholz appointed interim CFO on January 9, 2026, to serve through filing of the 2025 10‑K under an amended Transition and Separation Agreement.
• Exhibits: press release (Exhibit 99.1) and investor presentation (Exhibit 99.2) were furnished with the 8‑K.

Why It Matters

• The preliminary financial results will be material to investors but are not final; actual reported figures in the 10‑K may differ once audited and reviewed. Monitor the company’s forthcoming 10‑K and earnings release for finalized numbers.
• The appointment of an experienced finance executive and the interim CFO designation address leadership continuity in the finance function; Osberg’s compensation package and equity awards are sizable and may affect near‑term dilution and executive incentives.
• Investor presentation availability indicates the company is actively communicating with analysts and investors about strategy and results in January 2026; investors should review the furnished presentation and the final 10‑K for full context.